BioVie Inc. (NASDAQ:BIVIW) Shares Shorted: Short Interest Up 67.7% in October

BioVie Inc. (NASDAQ:BIVIW – Get Free Report) saw a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 50,400 shares, a growth of 67.7% from the October 15th total of 30,050 shares. Based on an average daily volume of 22,475 shares, the short-interest ratio is currently 2.2 days.

BioVie Stock Performance

NASDAQ BIVIW opened at $0.29 on Monday. BioVie has a one year low of $0.13 and a one year high of $0.79. The firm’s fifty day moving average is $0.30 and its two-hundred day moving average is $0.32.

BioVie Inc. is a clinical-stage biopharmaceutical company developing treatments for liver and neurological disorders. Its research includes therapies for conditions associated with inflammation and impaired organ function. The company’s development programs include BIV201, an investigational continuous-infusion formulation of terlipressin being studied for ascites associated with cirrhosis, and NE3107, an investigational oral drug candidate being studied for neurodegenerative diseases, including Alzheimer’s and Parkinson’s disease.

See Also

Receive News & Ratings for BioVie Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioVie and related companies with MarketBeat.com's FREE daily email newsletter.